核医学用ラジオアイソトープ市場：製品タイプ、用途、エンドユーザー別-2025～2030年の世界予測

核医療放射性同位元素市場は、2023年に104億6,000万米ドルと評価され、2024年には119億4,000万米ドルに達すると予測され、CAGR 14.50％で成長し、2030年には270億米ドルに達すると予測されています。

核医療放射性同位元素は、医療セグメントにおける診断と治療用途に使用される放射性物質であり、PETやSPECTスキャンなどのイメージング技術に不可欠なツールとしての役割を果たします。その必要性は、生物学的プロセスの詳細かつ非侵襲的な可視化や、がん、心血管疾患、神経疾患などの治療が可能であることに起因します。最終用途には主に病院、診断センター、研究機関が含まれます。市場成長は主に、慢性疾患の有病率の増加、技術の進歩、早期診断に関する意識の高まりの影響を受けています。しかし、処置にかかるコストの高さ、規制上の課題、放射性物質を含む安全プロトコルの厳格な遵守の必要性などの要因により、市場は制限されています。放射性同位元素製造の主要成分であるモリブデン-99のような材料のサプライチェーンも、その複雑かつ限定的な性質ゆえにボトルネックとなりえます。より効率的で費用対効果の高いアイソトープを開発し、腫瘍学以外のセグメント、特に神経学や心臓病学への応用を拡大することに機会があります。研究機関と営利企業との協力パートナーシップは、技術開発と臨床採用のギャップを埋めることにより、イノベーションを強化することができます。このような機会を生かすためには、利害関係者が、診断能力と治療能力を統合した標的α療法やセラノスティクスなど、新規アイソトープ生産法の先端研究に投資することが不可欠です。また、放射性同位元素の応用精度を高め、副作用を軽減し、治療効果を高めるための送達システムの改善からも、イノベーションが生まれる可能性があります。市場競争は激しいもの、セグメント化されたままであるため、これらの主要課題に対処し、革新的ソリューションや戦略的提携を通じて市場力学に影響を与えることのできる企業が参入する余地があります。市場の性質は進歩的だが、技術の進歩や規制の変更に対応するための適応戦略が必要です。

市場力学：急速に進化する核医療放射性同位元素市場の主要市場洞察を公開

核医療放射性同位元素市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • SPECT、PETスキャン、核医療に対するニーズの高まり
  • 放射性医薬品市場の著しい成長
  • がんと心臓疾患の有病率の増加
• 市場抑制要因
  • 高被ばくによる副作用
• 市場機会
  • 放射線療法の大幅な成長
  • 核医療におけるセラノスティクスの人気の高まり
• 市場課題
  • 厳しい政府規制

ポーターのファイブフォース：核医療放射性同位元素市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：核医療放射性同位元素市場における外部からの影響の把握

外部マクロ環境要因は、核医療放射性同位元素市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：核医療放射性同位元素市場における競合情勢の把握

核医療放射性同位元素市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：核医療放射性同位元素市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、核医療放射性同位元素市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：核医療放射性同位元素市場における成功への道筋を描く

核医療放射性同位元素市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • SPECT、PETスキャン、核医療の需要の高まり
    • 放射性医薬品の著しい成長
    • がんや心臓疾患の罹患率の増加
  • 抑制要因
    • 曝露量が多いと副作用が出る
  • 機会
    • 放射線治療の大幅な増加
    • 核医療におけるセラノスティクスの人気の高まり
  • 課題
    • 厳しい政府規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 核医療放射性同位元素市場：製品タイプ別

• イントロダクション
• 診断
  • フッ素18
  • ガリウム67
  • テクネチウム99
  • タリウム201
• 治療
  • ヨウ素131
  • レニウム186
  • サマリウム153
  • イットリウム90

第7章 核医療放射性同位元素市場：用途別

• イントロダクション
• 消化器内科
• 神経学
• 腫瘍学
• 整形外科

第8章 核医療放射性同位元素市場：エンドユーザー別

• イントロダクション
• 診断センター
• 教育・研究機関
• 病院
• 専門クリニック

第9章 南北アメリカの核医療放射性同位元素市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の核医療放射性同位元素市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの核医療放射性同位元素市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bruce Power Inc.
• Eckert & Ziegler Strahlen-und Medizintechnik AG
• General Atomics Electromagnetic Systems
• Grantek Systems
• International Isotopes Inc.
• Medical Isotopes, Inc.
• NorthStar Medical Radioisotopes, LLC
• Nuclear Research and consultancy Group
• Ontario Power Generation Inc.
• Orano Group
• ROSATOM State Atomic Energy Corporation
• SHINE Technologies, LLC
• SOFIE Co.
• Urenco Stable Isotopes

LIST OF FIGURES

• FIGURE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET RESEARCH PROCESS
• FIGURE 2. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUCLEAR MEDICINE RADIOISOTOPES MARKET DYNAMICS
• TABLE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GALLIUM-67, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THALLIUM-201, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 49. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 76. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 81. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 167. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 187. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 192. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 240. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023

The Nuclear Medicine Radioisotopes Market was valued at USD 10.46 billion in 2023, expected to reach USD 11.94 billion in 2024, and is projected to grow at a CAGR of 14.50%, to USD 27.00 billion by 2030.

Nuclear medicine radioisotopes are radioactive substances used in diagnostic and therapeutic applications within the medical field, serving as vital tools for imaging techniques such as PET and SPECT scans. Their necessity arises from their capacity to provide detailed, non-invasive visualization of biological processes and treatment of conditions like cancer, cardiovascular diseases, and neurological disorders. The end-use scope primarily includes hospitals, diagnostic centers, and research institutions. Market growth is primarily influenced by the increasing prevalence of chronic diseases, technological advancements, and growing awareness regarding early diagnostics. However, the market is limited by factors such as high costs of procedures, regulatory challenges, and the need for strict compliance with safety protocols involving radioactive materials. The supply chain for materials like Molybdenum-99, a key component in radioisotope production, can also be a bottleneck due to its complex and limited nature. Opportunities lie in the development of more efficient and cost-effective isotopes and expanding applications beyond oncology, particularly in neurology and cardiology. Collaborative partnerships between research institutions and commercial enterprises can enhance innovation by bridging gaps between technology development and clinical adoption. To capitalize on these opportunities, it is essential that stakeholders invest in advanced research for novel isotope production methods, such as targeted alpha therapy and theranostics, which integrate diagnostic and therapeutic capabilities. Innovation can also emerge from improving delivery systems to enhance the precision of radioisotope applications, reducing side effects, and increasing therapeutic efficacy. While the market is competitive, it remains fragmented, providing room for entrants who can address these key challenges and influence market dynamics through innovative solutions and strategic alliances. The nature of the market is progressive but requires adaptive strategies to stay aligned with technological advancements and regulatory changes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need for SPECT, PET scan and nuclear medicine
  • Remarkable growth of radiopharmaceutical drugs
  • Increasing prevalence of cancer and cardiac disorders
• Market Restraints
  • Side effects with higher exposure
• Market Opportunities
  • Substantial growth of radiation therapy
  • Emerging popularity of theranostics in nuclear medicine
• Market Challenges
  • Stringent government regulations

Porter's Five Forces: A Strategic Tool for Navigating the Nuclear Medicine Radioisotopes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nuclear Medicine Radioisotopes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nuclear Medicine Radioisotopes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nuclear Medicine Radioisotopes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nuclear Medicine Radioisotopes Market

A detailed market share analysis in the Nuclear Medicine Radioisotopes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nuclear Medicine Radioisotopes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nuclear Medicine Radioisotopes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nuclear Medicine Radioisotopes Market

A strategic analysis of the Nuclear Medicine Radioisotopes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Radioisotopes Market, highlighting leading vendors and their innovative profiles. These include Bruce Power Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, General Atomics Electromagnetic Systems, Grantek Systems, International Isotopes Inc., Medical Isotopes, Inc., NorthStar Medical Radioisotopes, LLC, Nuclear Research and consultancy Group, Ontario Power Generation Inc., Orano Group, ROSATOM State Atomic Energy Corporation, SHINE Technologies, LLC, SOFIE Co., and Urenco Stable Isotopes.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Radioisotopes Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Diagnostics and Therapeutic. The Diagnostics is further studied across Fluorine-18, Gallium-67, Technetium-99, and Thallium-201. The Therapeutic is further studied across Iodine-131, Rhenium-186, Samarium-153, and Yttrium-90.
• Based on Application, market is studied across Gastroenterology, Neurology, Oncology, and Orthopedics.
• Based on End-User, market is studied across Diagnostic Centers, Education & Research Institutes, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for SPECT, PET scan and nuclear medicine
    • 5.1.1.2. Remarkable growth of radiopharmaceutical drugs
    • 5.1.1.3. Increasing prevalence of cancer and cardiac disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects with higher exposure
  • 5.1.3. Opportunities
    • 5.1.3.1. Substantial growth of radiation therapy
    • 5.1.3.2. Emerging popularity of theranostics in nuclear medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nuclear Medicine Radioisotopes Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostics
  • 6.2.1. Fluorine-18
  • 6.2.2. Gallium-67
  • 6.2.3. Technetium-99
  • 6.2.4. Thallium-201
• 6.3. Therapeutic
  • 6.3.1. Iodine-131
  • 6.3.2. Rhenium-186
  • 6.3.3. Samarium-153
  • 6.3.4. Yttrium-90

7. Nuclear Medicine Radioisotopes Market, by Application

• 7.1. Introduction
• 7.2. Gastroenterology
• 7.3. Neurology
• 7.4. Oncology
• 7.5. Orthopedics

8. Nuclear Medicine Radioisotopes Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Education & Research Institutes
• 8.4. Hospitals
• 8.5. Specialty Clinics

9. Americas Nuclear Medicine Radioisotopes Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Nuclear Medicine Radioisotopes Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Nuclear Medicine Radioisotopes Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bruce Power Inc.
• 2. Eckert & Ziegler Strahlen- und Medizintechnik AG
• 3. General Atomics Electromagnetic Systems
• 4. Grantek Systems
• 5. International Isotopes Inc.
• 6. Medical Isotopes, Inc.
• 7. NorthStar Medical Radioisotopes, LLC
• 8. Nuclear Research and consultancy Group
• 9. Ontario Power Generation Inc.
• 10. Orano Group
• 11. ROSATOM State Atomic Energy Corporation
• 12. SHINE Technologies, LLC
• 13. SOFIE Co.
• 14. Urenco Stable Isotopes